Eloxx Pharmaceuticals
Eloxx Pharmaceuticals focuses on the discovery, development, and commercialization of compounds for the treatment of rare genetic diseases, including cystic fibrosis, Duchenne muscular dystrophy, Usher syndrome, ataxia-telangiectasia, beta thalassemi. Learn more
Launch date
Employees
Market cap
AUD2.9k
Enterprise valuation
AUD2m (Public information from Sep 2024)
Share price
$0.0006 ELOX
Watertown Massachusetts (HQ)
Authorizing premium user...